February 06. 2012 2:00AM - Last modified: March 16. 2012 9:36AM

MADISON - Novelos cancer drug in three trials at UW Hospital

  
Novelos Therapeutics, Madison, is starting a new phase of tests of its cancer-fighting drug known as iodine-131-CLR 1404, nicknamed HOT. That means the compound will be in three separate trials at the same time at the UW Hospital Carbone Cancer Center: two to see how well it shows images of cancerous tumors and one to see how large of a dose can be tolerated to treat cancers.

Novelos Therapeutics, Madison, is starting a new phase of tests of its cancer-fighting drug known as iodine-131-CLR 1404, nicknamed HOT. That means the compound will be in three separate trials at the same time at the UW Hospital Carbone Cancer Center: two to see how well it shows images of cancerous tumors and one to see how large of a dose can be tolerated to treat cancers.


advertisement
advertisement